00:00
42:47
Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies.
Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies. leggi di più leggi meno

8 anni fa #017, #brahmer, #cancergrace, #checkmate, #checkpoint, #exposure, #grace, #gracecast, #hopkins, #immune, #immunotherapy, #ipilimumab, #johns, #julie, #nivolumab, #opdivo, #pd1, #pdl1, #tobacco, #university